Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyCOTTU, P. H ; EXTRA, J. M ; CUVIER, C ; MARTY, M ; ESPIE, M ; MAROLLEAU, J. P ; DE ROQUANCOURT, A ; MAKKE, J ; MICLEA, J. M ; LAURENCE, V ; MAYEUR, D ; LEREBOURS, FBritish journal of cancer, 2001-11, Vol.85 (9), p.1240-1246 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trialCOLOMBO, N ; MCMEEKIN, D. S ; EINSTEIN, M. H ; HALUSKA, F ; SCHWARTZ, P. E ; SESSA, C ; GEHRIG, P. A ; HOLLOWAY, R ; BRALY, P ; MATEI, D ; MOROSKY, A ; DODION, P. FBritish journal of cancer, 2013-03, Vol.108 (5), p.1021-1026 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasiaDAAYANA, S ; ELKORD, E ; WINTERS, U ; PAWLITA, M ; RODEN, R ; STERN, P. L ; KITCHENER, H. CBritish journal of cancer, 2010-03, Vol.102 (7), p.1129-1136 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinomaBENGALA, C ; GUARNERI, V ; RICCI, S ; MOSCA, F ; DEL TACCA, M ; CONTE, P. F ; GIOVANNETTI, E ; LENCIONI, M ; FONTANA, E ; MEY, V ; FONTANA, A ; BOGGI, U ; DEL CHIARO, M ; DANESI, RBritish journal of cancer, 2005-07, Vol.93 (1), p.35-40 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancerLANGELOTZ, C ; SCHMID, P ; JAKOB, C ; HEIDER, U ; WERNECKE, K. D ; POSSINGER, K ; SEZER, OBritish journal of cancer, 2003-05, Vol.88 (9), p.1406-1410 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyBENGALA, C ; ZAMAGNI, C ; JOVIC, G ; GUARNERI, V ; MAUR, M ; CONTE, P. F ; PEDRAZZOLI, P ; MATTEUCCI, P ; BALLESTRERO, A ; DA PRADA, G ; MARTINO, M ; ROSTI, G ; DANOVA, M ; BREGNI, MBritish journal of cancer, 2006-04, Vol.94 (7), p.1016-1020 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |